Electroacupuncture for mammary hyperplasia: a randomized controlled trial

Authors
Category Primary study
Registry of TrialsITMCTR
Year 2022
INTERVENTION: Treatment group:electropuncture;control group:sham electropuncture ; CONDITION: hyperplasia of mammary glands PRIMARY OUTCOME: VAS score of breast pain; SECONDARY OUTCOME: Serum se Xhormone levels;Assessment of emotional state (SAS and SDS Self‐rating Scales);Number of days with significant breast pain;Quality of Life Scale (SF‐12 Scale);Breast mass size changes; INCLUSION CRITERIA: 1)Meet the diagnostic criteria of mammary hyperplasia; 2)VAS score > 3 for most painful breast pain in 7 days before menstruation in previous menstrual cycle;3)Women aged between 18 and 55 with regular menstrual cycle ( 28±7 days), and menstrual period (3‐7 days);4)have not used Chinese / Western medicine or acupuncture treatment for breast hyperplasia in the past 3 months; 5)signed informed consent and are willing to cooperate with the treatment. Note: patients who meet the above 5 criteria were eligible.
Epistemonikos ID: afceb895e5d444facf646497946ac19c0e7e95a8
First added on: Aug 26, 2024